Clinical trial
A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas
NCT00087997 is registered in ClinicalTrials.gov with Synta Pharmaceuticals Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas
- Lead sponsor
- Synta Pharmaceuticals Corp.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- October 31, 2005
- Enrollment
- 80
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
soft tissue sarcoma